SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-23-004764
Filing Date
2023-01-09
Accepted
2023-01-09 16:19:57
Documents
2
Group Members
CHEN YUTCG CROSSOVER FUND I, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D d432013dsc13d.htm SC 13D 88931
2 EX-99.1 d432013dex991.htm EX-99.1 6761
  Complete submission text file 0001193125-23-004764.txt   97569
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Subject) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: SC 13D | Act: 34 | File No.: 005-88797 | Film No.: 23518327
SIC: 2834 Pharmaceutical Preparations

Mailing Address 228 HAMILTON AVENUE, 3RD FLOOR PALO ALTO CA 94301
Business Address 228 HAMILTON AVENUE, 3RD FLOOR PALO ALTO CA 94301 650-798-5495
TCG Crossover GP I, LLC (Filed by) CIK: 0001839947 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D